2022
Innate and Adaptive Immunity to Transfused Allogeneic RBCs in Mice Requires MyD88.
Soldatenko A, Hoyt LR, Xu L, Calabro S, Lewis SM, Gallman AE, Hudson KE, Stowell SR, Luckey CJ, Zimring JC, Liu D, Santhanakrishnan M, Hendrickson JE, Eisenbarth SC. Innate and Adaptive Immunity to Transfused Allogeneic RBCs in Mice Requires MyD88. The Journal Of Immunology 2022, 208: 991-997. PMID: 35039331, PMCID: PMC10107373, DOI: 10.4049/jimmunol.2100784.Peer-Reviewed Original ResearchConceptsPattern recognition receptorsDendritic cellsDC activationAdaptive immunityClass of PRRsNon-ABO alloantibodiesRecipient dendritic cellsSplenic dendritic cellsMouse RBCsInflammatory cytokine responseTreatment of anemiaRBC transfusion therapyTransfused RBCsAlloantibody responsesAllogeneic RBCsSerious complicationsCytokine responsesTransfusion therapyRecognition receptorsMyD88TransfusionAlloimmunizationRBCsTRIFUnknown mechanism
2009
Chapter 47 Transfusion of HIV-positive Patients
Hendrickson J, Roback J. Chapter 47 Transfusion of HIV-positive Patients. 2009, 275-278. DOI: 10.1016/b978-0-12-374432-6.00047-6.Peer-Reviewed Original ResearchHIV-positive patientsAcquired Immunodeficiency SyndromeHuman immunodeficiency virusMultiple hematologic abnormalitiesSevere symptomatic anemiaUnderlying HIV infectionTransfusion of RBCsPotential immunomodulatory roleTransfusion-transmitted virusesTreatment of anemiaHIV diseaseSymptomatic anemiaHIV infectionImmunodeficiency syndromePlatelet transfusionsSevere thrombocytopeniaImmunodeficiency virusImmunomodulatory roleHematologic abnormalitiesHematologic conditionsVitamin deficiencyIneffective hematopoiesisTransfusionPatientsAdvanced stage